Treatment with TNFi was associated with increased adherence and drug survival when compared with IL-17i and JAKi in patients with ankylosing spondylitis.
Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback